Mallinckrodt and Endo complete merger deal Drugmakers Mallinckrodt and Endo have today completed their near $7 billion merger deal, which was first announced in March. Business • 01 Aug
Mallinckrodt and Endo complete merger deal Drugmakers Mallinckrodt and Endo have today completed their near $7 billion merger deal, which was first announced in March. Business • 01 Aug
Mallinckrodt and Endo to merge in near $7 billion deal Mallinckrodt and Endo, drugmakers with a shared history of facing bankruptcy and US opioid litigation, have agreed to merge in a deal valued at nearly $7 billion. Business • 13 Mar
Mallinckrodt and Endo to merge in near $7 billion deal Mallinckrodt and Endo, drugmakers with a shared history of facing bankruptcy and US opioid litigation, have agreed to merge in a deal valued at nearly $7 billion. Business • 13 Mar
Interim examiner appointed to Mallinckrodt again The High Court has appointed an interim examiner to Dublin-based but US-run pharmaceutical company Mallinckrodt for the second time in 15 months. Business • 20 Sep 23
Interim examiner appointed to Mallinckrodt again The High Court has appointed an interim examiner to Dublin-based but US-run pharmaceutical company Mallinckrodt for the second time in 15 months. Business • 20 Sep 23
Mallinckrodt files for bankruptcy Drugmaker Mallinckrodt has said the company and some of its units have filed for a second bankruptcy in 3 years in the U.S., with the newest restructuring plan set to reduce its debt by about $1.9 billion. Business • 28 Aug 23
Mallinckrodt files for bankruptcy Drugmaker Mallinckrodt has said the company and some of its units have filed for a second bankruptcy in 3 years in the U.S., with the newest restructuring plan set to reduce its debt by about $1.9 billion. Business • 28 Aug 23
Mallinckrodt plans to file for examinership Mallinckrodt said today it was planning to initiate Chapter 11 bankruptcy proceedings for the second time in three years. Business • 28 Aug 23
Mallinckrodt plans to file for examinership Mallinckrodt said today it was planning to initiate Chapter 11 bankruptcy proceedings for the second time in three years. Business • 28 Aug 23
Mallinckrodt moves toward second bankruptcy filing Mallinckrodt has said it was preparing to seek bankruptcy protection for the second time in three years after struggling to make a required $200m settlement payment to opioid victims. Business • 16 Aug 23
Mallinckrodt moves toward second bankruptcy filing Mallinckrodt has said it was preparing to seek bankruptcy protection for the second time in three years after struggling to make a required $200m settlement payment to opioid victims. Business • 16 Aug 23
Mallinckrodt seeks examinership amid restructuring US pharmaceutical company Mallinckrodt is heading for examinership here in as efforts to agree a debt restructuring deal in the US have been agreed. Business • 04 Feb 22
Mallinckrodt seeks examinership amid restructuring US pharmaceutical company Mallinckrodt is heading for examinership here in as efforts to agree a debt restructuring deal in the US have been agreed. Business • 04 Feb 22
Mallinckrodt to create 45 jobs at new Dublin centre Pharmaceutical company Mallinckrodt is to create 45 high-skilled jobs at its new medical device engineering centre in Blanchardstown in Dublin. Business • 15 May 17
Mallinckrodt to create 45 jobs at new Dublin centre Pharmaceutical company Mallinckrodt is to create 45 high-skilled jobs at its new medical device engineering centre in Blanchardstown in Dublin. Business • 15 May 17
Mallinckrodt to create new jobs in €45m expansion A multinational pharmaceutical company is promising 45 jobs in an €45m expansion of it Dublin operations by building a new manufacturing facility. Business • 20 May 15
Mallinckrodt to create new jobs in €45m expansion A multinational pharmaceutical company is promising 45 jobs in an €45m expansion of it Dublin operations by building a new manufacturing facility. Business • 20 May 15
Mallinckrodt to buy Questcor Pharma for $5.6bn Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals in a roughly $5.6bn cash-and-stock deal expected to expand the firm's drive in the speciality drugs field, the companies have announced. Business • 07 Apr 14
Mallinckrodt to buy Questcor Pharma for $5.6bn Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals in a roughly $5.6bn cash-and-stock deal expected to expand the firm's drive in the speciality drugs field, the companies have announced. Business • 07 Apr 14
